These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2820088)

  • 1. Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS
    Toxicol Lett; 1987 Sep; 38(1-2):67-76. PubMed ID: 2820088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS; Graham JH
    Toxicol Lett; 1988 Sep; 42(3):291-9. PubMed ID: 3176058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine.
    Buccafusco JJ; Graham JH; Aronstam RS
    Pharmacol Biochem Behav; 1988 Feb; 29(2):309-13. PubMed ID: 3362926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
    Buccafusco JJ; Aronstam RS
    J Pharmacol Exp Ther; 1986 Oct; 239(1):43-7. PubMed ID: 3761196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine prevents the short-term down regulation of muscarinic receptors in mouse brain induced by the acetylcholinesterase inhibitor soman.
    Aronstam RS; Smith MD; Buccafusco JJ
    Neurosci Lett; 1987 Jul; 78(1):107-12. PubMed ID: 3614769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
    Buccafusco JJ; Li W
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine.
    Buccafusco JJ; Heithold DL; Chon SH
    Toxicol Lett; 1990 Aug; 52(3):319-29. PubMed ID: 2389260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine protection from soman and echothiophate toxicity in mice.
    Aronstam RS; Smith MD; Buccafusco JJ
    Life Sci; 1986 Dec; 39(22):2097-102. PubMed ID: 3784771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman.
    Buccafusco JJ; Graham JH; VanLingen J; Aronstam RS
    Neurotoxicol Teratol; 1989; 11(1):39-44. PubMed ID: 2725439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive synergism of MD-354 and clonidine. Part II. The alpha-adrenoceptor component.
    Young S; Vainio M; Scheinin M; Dukat M
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):690-7. PubMed ID: 20353485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.
    Carlsson M; Carlsson A
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):317-22. PubMed ID: 2557047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between alpha 2- and beta-adrenergic receptors in rat cerebral cortical membranes: clonidine-induced reduction in agonist and antagonist affinity for beta-adrenergic receptors.
    Nakamura T; Tsujimura R; Nomura J
    Brain Res; 1991 Mar; 542(2):181-6. PubMed ID: 1851449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the clonidine-induced protection against acetylcholinesterase inhibitor toxicity.
    Buccafusco JJ
    J Pharmacol Exp Ther; 1982 Sep; 222(3):595-9. PubMed ID: 6286926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
    Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of imidazenil against chemical warfare nerve agent soman toxicity in guinea pigs.
    Wang Y; Oguntayo S; Wei Y; Wood E; Brown A; Jensen N; Auta J; Guiodotti A; Doctor BP; Nambiar MP
    Neurotoxicology; 2012 Mar; 33(2):169-77. PubMed ID: 22245390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against both lethal and behavioral effects of soman.
    Harris LW; McDonough JH; Stitcher DL; Lennox WJ
    Drug Chem Toxicol; 1984; 7(6):605-24. PubMed ID: 6534735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of lateral geniculate neurons by norepinephrine: mediation by an alpha-adrenergic receptor.
    Rogawski MA; Aghajanian GK
    Brain Res; 1980 Jan; 182(2):345-59. PubMed ID: 6101983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine.
    Magrí V; Buccafusco JJ; Aronstam RS
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):464-73. PubMed ID: 3188010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.